Treatment of Breast Cancer with 5-Fluorouracil
- 1 October 1962
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 57 (4) , 598-605
- https://doi.org/10.7326/0003-4819-57-4-598
Abstract
Toxic manifestations involving the gastrointestinal tract and bone marrow were almost universally observed and often reached serious proportions following the first course of therapy. Five patients achieved an objective response of 7 months or longer, and six experienced a subjective response of 5 months or longer. It is suggested that subjective responses are as valuable as objective responses, since the purpose of chemotherapy in patients with far-advanced cancer of the breast is palliation rather than cure. Approximately 50% of patients treated can expect to be benefited.Keywords
This publication has 4 references indexed in Scilit:
- The Role of 5-Fluorouracil in Malignant DiseaseAnnals of Internal Medicine, 1961
- An Evaluation of 5-Fluorouracil in Malignant DiseaseAnnals of Internal Medicine, 1961
- THE COMPARATIVE UTILIZATION OF URACIL-2-C-14 BY LIVER, INTESTINAL MUCOSA, AND FLEXNER-JOBLING CARCINOMA IN THE RAT1957
- STUDIES IN 2-ACETYLAMINOFLUORENE CARCINOGENESIS .3. THE UTILIZATION OF URACIL-2-C-14 BY PRENEOPLASTIC RAT LIVER AND RAT HEPATOMA1954